Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.Explore and learn more about Conference Series : World's leading Event Organizer
Aplastic anemia is a condition where the bone marrow fails to produce enough blood cells. The cells in the bone marrow itself are damaged and so white blood cells, red blood cells and platelets are produced in very low numbers. If your bone marrow can't make enough new blood cells, many health problems can occur. These problems include arrhythmias,an enlarged heart, heart failure, infections, and bleeding. Severe aplastic anemia can even be fatal. The causes are unknown and many factors like viral infection, exposure to chemicals and radiation, use of certain drugs and Auto-Immune disorders have been attributed to this condition.The treatments vary according to the underlying cause, for example immune mediated aplastic anemia is treated by immune-suppressants.The most serious cases require a bone marrow transplant. Mostly Hematologists, oncologists and orthopedics are specialized in this kind of transplantation surgeries.
The disease is fatal and results in death if proper precautions and medications are not followed. The two types of Bone Marrow are medulla ossium rubra, which consists mostly of hematopoietic tissue, and medulla ossium flava , which is mainly made up of fat cells. Red blood cells, platelets, and most white blood cells arise in red marrow. Both types of bone marrow include numerous blood vessels and capillaries. By birth, all bone marrow is red. With age, extra of it is converted to the yellow type; only around half of adult bone marrow is red. Red marrow is originate mainly in the flat bones, such as the pelvis,sternum, cranium, ribs, vertebrae and scapulae, and in the cancellous ("spongy") material at the epiphyseal ends of long bones such as the femur and humerus. Yellow marrow is found in the medullary cavity, the hollow interior of the middle portion of long bones. In cases of ruthless blood loss, the body can convert yellow marrow back to red marrow to enhance blood cell production.
Hematology conferences, workshops and symposiums are an excellent platform to share and experience the latest advancement in the diagnosis, treatment and research methodologies.
OMICS Group is an amalgamation of Open Access publications and international science conferences. Established in the year 2007 with the sole aim of making the information on Science and technology ‘Open Access’, OMICS Group publishes 400 online open access scholarly journals in Science, Engineering, Management and Technology. OMICS International Conferences sets an ideal path for international association triggering and inspiring scientific society with the newest research work. The Symposia, workshops and exhibitions are the key specialties of the OMICS Group Meetings. The Scientific world and business delegates at the conferences have praised the conferences for their networking opportunities in its B2B and Scientific Meetings.OMICS Group adds value to its conventions by identifying outstanding speakers and delegates from various parts of the world.
Associations
Aplastic Anemia and MDS International Foundation
The Aplastic Anaemia Trust
The Myelodysplastic Syndromes Foundation
Canadian Organization for Rare Disorders
Canadian Hemophilia Society
Network of Rare Blood Disorder Organizations
Asia-pacific Blood and Marrow transplantation Group
Aplastic Anemia and Myelodysplasia Association of Canada
NIH/National Heart, Lung and Blood Institute
National Organization for Rare Disorders
Aplastic Anemia Association of India
American Society of Hematology
American Society for Blood and Marrow transplantation
Fanconi Anemia Research Fund
Leukemia & Lymphoma Society of Canada
European Society of Blood and Marrow Transplantation
Conferences
4th International Bone Marrow Failure Disease Scientific Symposium 2014
19th Congress of APBMT, Hangzhou, China
41st Annual Meeting of the European Society of Blood and Marrow Transplantation (EBMT 2015)
3rd International Conference on Hematology & Blood Disorders 2014
The 34th Annual Meeting of the Israel Orthopaedic Association (IOA) and The 2ndConference of the Mediterranean Trauma Society
UAE Cancer Congress
The 3rd annual World Cord Blood Congress 2014
Companies
Genzyme, Multinational
BDI Pharma, USA
Sanofi Oncology ,Multinational
Pfzier, Multinational
Roche, Switzerlan, Multinational
Novartis, Multinational
Cancer Quest , USA
Aranesp, USA
Amgen , USA, Multinational
Johnson & Johnson, Multinational
 
This page will be updated regularly.
This page was last updated on November 5, 2024
